Virginia Retirement Systems’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-33,200
| Closed | -$312K | – | 1196 |
|
|
2020
Q3 | $312K | Sell |
33,200
-19,700
| -37% | -$187K | ﹤0.01% | 920 |
|
|
2020
Q2 | $405K | Sell |
52,900
-9,100
| -15% | -$69.6K | ﹤0.01% | 871 |
|
|
2020
Q1 | $383K | Hold |
62,000
| – | – | 0.01% | 875 |
|
|
2019
Q4 | $755K | Sell |
62,000
-22,800
| -27% | -$249K | 0.01% | 810 |
|
|
2019
Q3 | $979K | Buy |
84,800
+4,400
| +5% | +$46.3K | 0.01% | 697 |
|
|
2019
Q2 | $803K | Buy |
+80,400
| New | +$867K | 0.01% | 751 |
|
|
2017
Q4 | – | Sell |
-64,000
| Closed | -$1.18M | – | 1091 |
|
|
2017
Q3 | $1.18M | Sell |
64,000
-14,400
| -18% | -$268K | 0.01% | 620 |
|
|
2017
Q2 | $1.44M | Buy |
78,400
+42,100
| +116% | +$834K | 0.02% | 555 |
|
|
2017
Q1 | $819K | Buy |
36,300
+19,700
| +119% | +$472K | 0.01% | 721 |
|
|
2016
Q4 | $578K | Sell |
16,600
-4,700
| -22% | -$140K | 0.01% | 718 |
|
|
2016
Q3 | $522K | Buy |
21,300
+3,500
| +20% | +$87.5K | 0.01% | 696 |
|
|
2016
Q2 | $426K | Buy |
+17,800
| New | +$408K | 0.01% | 750 |
|
|
2015
Q4 | $519K | Buy |
17,200
+5,400
| +46% | +$174K | 0.01% | 717 |
|
|
2015
Q3 | $469K | Buy |
11,800
+3,400
| +40% | +$211K | 0.01% | 713 |
|
|
2015
Q2 | $580K | Sell |
8,400
-1,600
| -16% | -$101K | 0.01% | 690 |
|
|
2015
Q1 | $547K | Buy |
+10,000
| New | +$477K | 0.01% | 695 |
|
Virginia Retirement Systems's AMAG Position: Q4 2020 in Review
Virginia Retirement Systems sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 33,200 shares — an estimated $312K sold.
Virginia Retirement Systems first reported a position in AMAG in Q1 2015 and held it in 16 quarters. The position peaked at $1.44M in Q2 2017. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Virginia Retirement Systems reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Virginia Retirement Systems sold 33,200 AMAG Pharmaceuticals shares in Q4 2020, an estimated $312K.
- Virginia Retirement Systems first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 16 quarters.
- Virginia Retirement Systems's AMAG Pharmaceuticals position peaked at $1.44M in Q2 2017.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Virginia Retirement Systems's 13F filing for Q4 2020, filed 16 Feb 2021.